BioLife Solutions: T. Rowe Price lists 2.2% position
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BioLife Solutions, Inc. (BLFS) is the issuer in an amended Schedule 13G that lists 1,094,026 common shares as beneficially owned by T. Rowe Price Investment Management, Inc., equal to 2.2% of the class. The table reports sole voting and dispositive power over all 1,094,026 shares and no shared power. T. Rowe Price Investment Management expressly denies being the beneficial owner of the securities.
Key Figures
Key Terms
beneficial ownership regulatory
sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.